Expect Improvements to Your State's Rx Drug Monitoring Program

You'll hear about major changes ahead to make opioid use safer and lessen barriers to treatment of opioid dependence.

This is partly due to new initiatives including the landmark Comprehensive Addiction and Recovery Act, signed in July 2016.

Prescription drug monitoring programs (PDMPs) will be strengthened to make them easier to use and more effective.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote